Profile picture

Doctor Samuel Dagogo-Jack

Memphis (United States of America)
Follow
Logo ESC

Contributor content

VERTIS CV Safety Results and Conclusions.
Presentation
VERTIS CV Safety Results and Conclusions.
Read more
VERTIS CV – New Information For the Treatment for Patients With Type 2 Diabetes and Cardiovascular Disease.
Presentation
VERTIS CV – New Information For the Treatment for Patients With Type 2 Diabetes and Cardiovascular Disease.
Read more
Envisioning the future of SGLT2 inhibitors in the treatment of patients with diabetes and cardiovascular disease: a roundtable discussion.
Presentation
Envisioning the future of SGLT2 inhibitors in the treatment of patients with diabetes and cardiovascular disease: a roundtable discussion.
Read more
Questions & Answers.
Presentation
Questions & Answers.
Read more
Ertugliflozin – A newly emerging SGLT2 inhibitor for patients with type 2 diabetes.
Presentation
Ertugliflozin – A newly emerging SGLT2 inhibitor for patients with type 2 diabetes.
Read more